Very severe immune aplastic anemia after mRNA vaccination against COVID-19 responds well to immunosuppressive therapy: clinical characteristics and comparison to previous reports.

Suhyeon Woo Bohyun Kim Sang-Cheol Lee Min Sun Kim Hyun Young Chi Young Ahn Yoon

Published in: Hematology (Amsterdam, Netherlands) (2022)

COVID-19 vaccine might be associated with the development of immune-mediated AA. Prompt hematologic evaluation should be performed when there are symptoms or signs suggestive of cytopenia after COVID-19 vaccination. Although the clinical outcome of post-vaccination AA varies, a good prognosis can be possible for patients with COVID-19 vaccination-induced AA.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
stem cells
emergency department
high glucose
early onset
endothelial cells
allogeneic hematopoietic stem cell transplantation
depressive symptoms
bone marrow
cell therapy
clinical evaluation
stress induced